Home » Topics » Regulatory » Patents

Patents
RSS

Pfizer reports neuroleptics

June 7, 1996

Asahi Chem. claims sigma-receptor ligands

June 7, 1996

Compounds with high affinity for 5-HT1A and/or D2 receptors reported by E. Merck

June 7, 1996

Bristol-Myers Squibb describes compounds with melatonergic properties

June 7, 1996

CDR-grafted type III anti-CEA MAbs identified

June 7, 1996

Hoescht reports imidobisphosphonic acid derivatives

June 7, 1996

Fujisawa claims ACAT inhibitors

June 7, 1996

Indena claims colchicine derivatives

June 7, 1996

E. Merck describes immunoconjugates

June 7, 1996

Knoll describes antiarthritic and immunomodulator derivatives

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 14, 2025.
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld Science
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
Anchoring, and bootstrapping, psychiatry into the precision medicine era
BioWorld
Psychiatry has struggled to enter the precision medicine era. But through a mix of innovations and bootstrapping, progress is coming to the field. Scientists are...